Investing in nature gives industry and business a competitive advantage.World Economic Forum, September 7, 2021 
The case as to why investing in nature is a sensible business proposition is made here. As more and more industry leaders understand that nature and economics are inextricably linked, the next business frontier lies at the intersection of climate change and biodiversity. It will entail: (1) changing the measures of growth, (2) incorporating the true value of nature into market pricing, and (3) ensuring that demands on nature do not exceed the ability to supply.

Meet Altos Labs, Silicon Valley’s latest wild bet on living forever–MIT Technology Review, September 4, 2021
The quest for eternal life is…eternal! Because “young people dream of being rich, and rich people dream of being young” (as this article states), billionaires like Jeff Bezos and Yuri Milner are funding rejuvenation start-ups that can harness biotechnology to make people younger. Their aim: to pursue biological reprogramming technology—a way to rejuvenate cells in the lab that some scientists think could be extended to revitalize entire animal bodies, ultimately greatly prolonging human life. Not a done deal, according to some scientists.

Some rich people are counting their antibodies ‘like calories’–New York Times, September 18, 2021
Medical concierge services are offering coronavirus antibody tests as a perk, despite some caveats about their usefulness, because there isn’t an agreed upon “right” antibody count. Regular antibody testing is becoming a common practice among anxious, well-heeled people.

The sexual wellness category had a stellar 2020, and in 2021, it’s poised for further growth fueled by a new wave of investors and retailers and the launch of new brands. As of August, there have been 115 VC deals in femtech ($812 million invested) just in the US. Brands in the sexual wellness category, such as Cake and Maude, are seeing major new funding.

A Striking Stat

23% of people globally are now trying to limit their intake of meat.